Switch to:
More From Other Websites
Alkermes to Host Conference Call to Discuss First Quarter 2015 Financial Results Apr 23 2015
Alkermes to Host Conference Call to Discuss First Quarter 2015 Financial Results Apr 23 2015
Alkermes to Host Conference Call to Discuss First Quarter 2015 Financial Results Apr 23 2015
ALKERMES PLC. Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements... Apr 16 2015
ALKERMES PLC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Apr 13 2015
Alkermes to Present Preclinical Data on Novel Selective Effector Cell Activator (SECA™)... Apr 13 2015
Alkermes to Present Preclinical Data on Novel Selective Effector Cell Activator (SECA™)... Apr 13 2015
Alkermes to Present Preclinical Data on Novel Selective Effector Cell Activator (SECA™)... Apr 13 2015
The Zacks Analyst Blog Highlights: Alkermes, Regulus, Juno Therapeutics, Targacept and Gilead -... Apr 09 2015
Alkermes Reports Encouraging Data on Schizophrenia Drug - Analyst Blog Apr 07 2015
Alkermes Announces Positive Topline Results from Complete Six-Month Phase 2 Clinical Trial of ALKS... Apr 06 2015
Alkermes Announces Positive Topline Results from Complete Six-Month Phase 2 Clinical Trial of ALKS... Apr 06 2015
Alkermes Announces Positive Topline Results from Complete Six-Month Phase 2 Clinical Trial of ALKS... Apr 06 2015
Biogen/AbbVie's MS Drug Zinbryta Under Review in the EU - Analyst Blog Mar 30 2015
Alkermes 'Taking A Pause,' Citi Says Mar 27 2015
Alkermes plc -- Moody's affirms Alkermes' Ba3 ratings; changes outlook to stable Mar 23 2015
Alkermes to Present Data on Aripiprazole Lauroxil and ALKS 3831 at 15th International Congress on... Mar 23 2015
Alkermes to Present Data on Aripiprazole Lauroxil and ALKS 3831 at 15th International Congress on... Mar 23 2015
Alkermes to Present Data on Aripiprazole Lauroxil and ALKS 3831 at 15th International Congress on... Mar 23 2015
Alkermes Streamlines Operations, Revises 2015 Guidance - Analyst Blog Mar 10 2015


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK